Trial Profile

Phase I/II Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection

Status: Not yet recruiting

Phase of Trial: Phase I/II

Latest Information Update: 29 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs INO 8000 (Primary) ; INO 9012
Indications Hepatitis C
Focus Adverse reactions
Sponsors Inovio Pharmaceuticals

Most Recent Events

28 Apr 2016 According to Inovio Pharmaceuticals media release, in April 2016, the company partnered with National Cancer Institute and Mayo Clinic to initiate this trial.
16 Apr 2015 Status changed from planning to not yet recruiting, according to ClinicalTrials.gov record.
13 Nov 2014 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com